2 results
Approved WMOCompleted
The main objective of Study M15-722 is to characterize the efficacy, safety, and tolerability of ravagalimab (ABBV-323) as induction treatment in subjects with moderately to severely active UC.
Approved WMOCompleted
Primary objective: To evaluate local implementation, safety, feasibility and efficacy of temporary RV support with the Impella RP circulatory support deviceSecondary objective: -To evaluate the effect of temporary RV support on several clinical and…